Insights

Multiplex Testing PathogenDx offers a patented multiplexed molecular testing platform (D3 Array) capable of detecting up to 50 pathogens in a single well, enabling faster, comprehensive pathogen screening for plants, food, and clinical samples—a compelling value proposition for labs seeking higher throughput and wider panels.

Unified Salmonella Solution The recent IPPE 2026 launch of a Unified Salmonella Testing System, along with SalSure Detect, SalSure Quant, Serox, and SalVac, positions PathogenDx to capture additional poultry processing and FSIS-aligned demand for rapid detection, quantification, serotyping, and vaccine identification.

Cloud Analytics Automated cloud-based analytics complements the hardware, appealing to labs and enterprises prioritizing remote monitoring, data integration, audit trails, and scalable reporting for compliance and decision support.

Industry Recognition Award recognition such as the 2024 North American New Product Innovation Award enhances credibility with potential customers and partners, easing outreach in competitive biomed/food safety markets.

Growth and Collaboration Strategic hires and advisory board expansion (e.g., Carl Wittwer joining the Board of Advisors) suggest a focus on scientific leadership and market credibility, which can open conversations with larger labs, contract manufacturers, and poultry producers seeking proven expertise and collaboration opportunities.

Similar companies to PathogenDx

PathogenDx Tech Stack

PathogenDx uses 8 technology products and services including LinkedIn Ads, HubSpot Analytics, iCIMS, and more. Explore PathogenDx's tech stack below.

Media & News

PathogenDx's Email Address Formats

PathogenDx uses at least 2 email formats:
PathogenDx Email FormatsExamplePercentage
FLast@pathogendx.comJDoe@pathogendx.com
96%
First@pathogendx.comJohn@pathogendx.com
4%

Frequently Asked Questions

What is PathogenDx's phone number?

Minus sign iconPlus sign icon
You can contact PathogenDx's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PathogenDx's official website and social media links?

Minus sign iconPlus sign icon
PathogenDx's official website is pathogendx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does PathogenDx generate?

Minus sign iconPlus sign icon
As of August 2026, PathogenDx's annual revenue is estimated to be $10M - $25M.

What is PathogenDx's SIC code and NAICS code?

Minus sign iconPlus sign icon
PathogenDx's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PathogenDx have currently?

Minus sign iconPlus sign icon
As of August 2026, PathogenDx has approximately 26 employees across 1 continents, including North America. Key team members include Director Of Sales And Marketing: M. M., Qms Specialist: L. R. and Scientific Advisor: C. Y. Explore PathogenDx's employee directory with LeadIQ.

What industry does PathogenDx belong to?

Minus sign iconPlus sign icon
PathogenDx operates in the Biotechnology Research industry.

What technology does PathogenDx use?

Minus sign iconPlus sign icon
PathogenDx's tech stack includes LinkedIn Ads, HubSpot Analytics, iCIMS, WordPress, Simpli.fi, Piwik, Vimeo and Piwik PRO Core.

What is PathogenDx's email format?

Minus sign iconPlus sign icon
PathogenDx's email format typically follows the pattern of FLast@pathogendx.com. Find more PathogenDx email formats with LeadIQ.

How much funding has PathogenDx raised to date?

Minus sign iconPlus sign icon
As of August 2026, PathogenDx has raised $12M in funding. The last funding round occurred on Oct 30, 2019 for $7.5M.
PathogenDx logo

PathogenDx

Biotechnology ResearchArizona, United States11-50 Employees

PathogenDx is a biotechnology company focused on developing testing kits, automation, and software to detect pathogens in plants, food, and humans. Its core multiplex molecular testing technology enables the rapid detection and identification of up to 50 pathogens within a single well, providing triplicate data to support confidence in results and faster decision-making. The system is designed to work with existing laboratory equipment, and analytics are automated through cloud-based software, simplifying workflow and data handling. Together, these capabilities address the needs of clinical, food safety, and agricultural testing by delivering higher throughput and more reliable results.

Headquartered in Scottsdale, Arizona, PathogenDx operates as a small-to-mid-sized biotechnology firm serving labs and producers across clinical, food safety, and agricultural sectors. In January 2026 the company announced a Unified Salmonella Testing System at IPPE 2026, reflecting an expansion of its testing solutions for Salmonella in poultry and related supply chains.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $12M

    PathogenDx has raised a total of $12M of funding over 5 rounds. Their latest funding round was raised on Oct 30, 2019 in the amount of $7.5M as a Series B.

  • $10M - $25M

    PathogenDx's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.